Delivery Order SPE2DB22D9207-SPE2DB25FH5FQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market while...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a direct pharmaceutical supply transaction under DMS's existing Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the awardee under a firm fixed-price contract type. The delivery order carries an ultimate completion date of July 11, 2025, with performance to be executed at the vendor's Park Ridge location. No...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The award carries no set-aside designation and represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a direct pharmaceutical supply transaction under DLA's established procurement framework. The contract carries no...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This $12,115.65 firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, and is not designated as a set-aside contract. The delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). The delivery order, valued at $39,374.50 with an ultimate completion date of September 9, 2025, represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program. No set-aside designation was...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units) under firm fixed-price terms. The contract, valued at $12,146.79 with an ultimate completion date of September 22, 2025, was awarded on September 19, 2025, with no set-aside designation applied. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 10 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this firm fixed-price delivery order with an ultimate completion date of September 10, 2025. The award was made without a set-aside designation, reflecting the vendor's competitive standing in federal...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $36,440.37 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this contract at its Park Ridge facility with an ultimate completion date of July 9, 2025. This delivery order was awarded without a set-aside designation on July 8, 2025. This...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB25FH5FQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,088.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The contract is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and was awarded on September 26, 2025. This award carries no set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million and valid through November 2026. The IDC, established under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. Jakafi is a prescription medication used in the treatment of certain blood disorders, consistent with the vendor's core business of supplying branded and generic prescription drugs, biologics, and specialized pharmaceutical products to military and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.1k | 9/26/25 |